Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Presentation
February 26, 2016

Combating Emerging and Re-Emerging Infectious Diseases in Clinical Trials by Harnessing Innovative Technologies

This presentation highlights the challenges of emerging and re-emerging infectious diseases such as MTB, HIV, MRSA, and Ebola.

This presentation also provides case studies on how innovative technologies like NGS are utilized to provide a deeper understanding of the pathogen and drug resistance pathways and thus provide better insights into developing diagnostics and therapies that are efficacious against the target pathogen and its resistant variants with improved safety. Download the presentation to learn more about the challenge of emerging infectious diseases.

Related Services:

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Read More